drugset / Trial / NCT05718531

Coronary Artery Ectasia, Efficacy of Various Anti Thrombotic Regimens.

NCT05718531

Phase 3 Unknown 200 enrolled Assiut University
RandomizedParallel-groupOpen-labelTreatment

Summary

1. To evaluate short and intermediate clinical outcome of different anti-thrombotic regimens on major adverse cardiac events (MACE) and quality of life in coronary artery ectasia patients. 2. To evaluate role of P-selectin as a marker of cardiovascular risk in coronary artery ectasia.

Timeline

Start
2023-02-01
Primary completion
2025-02
Completion
2025-08

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aspirin Small molecule 75 mg
Comparator Clopidogrel Small molecule 75 mg
Comparator Rivaroxaban Other / unclassified 2.5 mg Oral

Indications